Three Oral GLP-1 Formats Compared: FDA Pills vs. Compounded Troches vs. Sublingual Drops

⚡ TL;DR — OUR VERDICT

FDA-approved oral pills (Foundayo and oral Wegovy) have clinical trial data proving they work. Compounded sublingual drops and troches do not. The SNAC absorption enhancer that makes oral semaglutide work cannot be legally compounded, so compounded oral semaglutide faces a fundamental bioavailability problem. If you want an oral GLP-1, start with FDA-approved options.

The Oral Landscape in 2026

There are now three distinct categories of oral GLP-1 products, and they are not equivalent:

Format	FDA Approved?	Clinical Trial Data?	Known Bioavailability
Foundayo (orforglipron pill)	✅ Yes (April 2026)	✅ ATTAIN trials	High — small molecule, no enhancer needed
Oral Wegovy (semaglutide pill)	✅ Yes (Dec 2025)	✅ OASIS trials	Low (~1%) but compensated by SNAC enhancer + high dose
Compounded troches/sublingual	❌ No	❌ No controlled trials	Unknown/variable — no SNAC, absorption uncertain

The SNAC Problem with Compounded Oral Semaglutide

This is the technical issue that most compounded oral GLP-1 marketing glosses over. Oral semaglutide (Rybelsus/oral Wegovy) achieves measurable blood levels despite semaglutide's naturally poor oral bioavailability because it's co-formulated with SNAC (sodium N-[8-(2-hydroxybenzoyl)amino] caprylate) — a proprietary absorption enhancer that temporarily raises stomach pH and protects the peptide from degradation.

SNAC cannot be legally compounded. It's a patented excipient. Without it, oral semaglutide peptide is largely destroyed in the GI tract before it reaches the bloodstream. Compounded sublingual drops attempt to bypass this by absorbing through the mucous membranes under the tongue — but sublingual absorption of a large peptide like semaglutide is variable and unproven.

Foundayo: Why It Doesn't Need SNAC

Foundayo (orforglipron) sidesteps the entire problem. Unlike semaglutide, orforglipron is a small non-peptide molecule. It activates the same GLP-1 receptor but has a fundamentally different chemical structure that survives stomach acid and absorbs readily through the GI tract. No enhancer needed.

This is why Foundayo can be taken any time of day, with or without food, with any amount of water. Its bioavailability isn't dependent on fragile absorption conditions.

Compounded Oral Formats: What You're Getting

Troches (Lozenges)

Compounded semaglutide troches are designed to dissolve slowly in the mouth, with the drug absorbing through the buccal (cheek) and sublingual (under tongue) membranes. Efficacy varies by patient technique — swallowing too quickly reduces absorption. No published bioavailability data exists for this format.

Sublingual Drops

Liquid semaglutide held under the tongue for 5–15 minutes. Same absorption pathway as troches, same uncertainty about bioavailability. Some patients report good results; others report minimal appetite suppression compared to injectable.

ODT (Orally Disintegrating Tablets)

Similar to troches but designed to dissolve faster. Same bioavailability questions apply.

Cost Comparison

Format	Typical Cost	Evidence Level
Foundayo (brand)	$50/mo (Medicare Bridge) or retail	Phase 3 trials + FDA approval
Oral Wegovy (brand)	$50/mo (Medicare Bridge) or retail	Phase 3 trials + FDA approval
Compounded sublingual/troches	$99–$249/mo	No controlled trials
Compounded injectable sema	$99–$299/mo	Same molecule as Wegovy, proven bioavailability via injection

Key insight: If you want compounded AND proven bioavailability, compounded injectable semaglutide is a far safer bet than compounded oral formats. The injectable route delivers the drug directly to the bloodstream — no SNAC needed, no absorption uncertainty.

Recommended Providers

Brand-Name

Sesame Care

From $29/visit

Brand-name Foundayo and oral Wegovy prescriptions.

Compare →

Paid link · Compounded medications are not FDA-approved